Ameritas Investment Partners, Inc. - SYROS PHARMACEUTICALS INC ownership

SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 49 filers reported holding SYROS PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of SYROS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2022$4,000
-66.7%
3,6670.0%0.00%
Q4 2021$12,000
-25.0%
3,6670.0%0.00%
-100.0%
Q3 2021$16,000
-20.0%
3,6670.0%0.00%0.0%
Q2 2021$20,000
-25.9%
3,6670.0%0.00%0.0%
Q1 2021$27,000
-32.5%
3,6670.0%0.00%
-50.0%
Q4 2020$40,000
+25.0%
3,6670.0%0.00%
+100.0%
Q3 2020$32,000
-17.9%
3,6670.0%0.00%
-50.0%
Q2 2020$39,000
+160.0%
3,667
+40.9%
0.00%
+100.0%
Q1 2020$15,000
-16.7%
2,6020.0%0.00%0.0%
Q4 2019$18,000
-33.3%
2,6020.0%0.00%0.0%
Q3 2019$27,000
+12.5%
2,6020.0%0.00%0.0%
Q2 2019$24,0000.0%2,6020.0%0.00%0.0%
Q1 2019$24,000
+71.4%
2,6020.0%0.00%0.0%
Q4 2018$14,000
-54.8%
2,6020.0%0.00%0.0%
Q3 2018$31,000
+14.8%
2,6020.0%0.00%0.0%
Q2 2018$27,000
+92.9%
2,602
+137.0%
0.00%0.0%
Q1 2018$14,000
+27.3%
1,0980.0%0.00%0.0%
Q4 2017$11,000
-47.6%
1,0980.0%0.00%0.0%
Q3 2017$21,000
+16.7%
1,0980.0%0.00%0.0%
Q2 2017$18,000
+200.0%
1,098
+200.0%
0.00%
Q1 2017$6,0003660.00%
Other shareholders
SYROS PHARMACEUTICALS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 3,439,895$18,747,0004.66%
Bain Capital Life Sciences Investors, LLC 5,785,036$31,528,0002.07%
Omega Fund Management, LLC 2,274,831$12,398,0001.40%
Altium Capital Management LP 1,076,942$5,869,0001.36%
Samsara BioCapital, LLC 2,189,199$10,599,0001.31%
Sio Capital Management, LLC 800,000$4,360,0001.08%
Flagship Pioneering Inc. 2,938,494$16,015,0000.20%
EcoR1 Capital, LLC 1,000,000$5,450,0000.20%
Artal Group S.A. 1,700,000$9,265,0000.19%
ACT CAPITAL MANAGEMENT, LLC 52,500$287,0000.15%
View complete list of SYROS PHARMACEUTICALS INC shareholders